In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G aligns with WNBA

This article was originally published in The Rose Sheet

Executive Summary

Procter & Gamble and the Women's National Basketball Association have entered into a multi-year marketing partnership for promoting seven P&G brands targeted to women, including Secret, Head & Shoulders and Herbal Essences. Partnership will include advertising, cross-promotional activities and specific WNBA team sponsorships, P&G says. P&G will have a "major presence" on national WNBA telecasts on ABC, ESPN2, Oxygen and NBA TV through advertising and in-game enhancements, the company adds. In addition, WNBA players will make appearances on behalf of certain P&G brands, and the WNBA will be featured in P&G national consumer promotions through the duration of the partnership...

You may also be interested in...



Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011248

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel